Quality of life and pain in patients with metastatic bone disease from solid tumors treated with bone-targeted agents– a real-world cross-sectional study from Switzerland (SAKK 95/16)

被引：0
|
作者：
Karin Ribi
Beat Thürlimann
Corinne Schär
Daniel Dietrich
Richard Cathomas
Ursina Zürrer-Härdi
Thomas von Briel
Sandro Anchisi
Pierre Bohanes
Veronika Blum
Philippe von Burg
Meinrad Mannhart
Clemens B. Caspar
Roger von Moos
Michael Mark
机构：
[1] International Breast Cancer Study Group (IBCSG),
[2] Kantonsspital St. Gallen,undefined
[3] Swiss Group for Clinical Cancer Research (SAKK) Coordinating Center,undefined
[4] Kantonsspital Graubünden,undefined
[5] Kantonsspital Winterthur,undefined
[6] Klinik Hirslanden,undefined
[7] Hôpital du Valais,undefined
[8] Centre de Chimiothérapie Anti-Cancéreuse,undefined
[9] Kantonsspital Luzern,undefined
[10] Burgerspital Solothurn,undefined
[11] Andreasklinik Cham Zug,undefined
[12] Kantonsspital Baden,undefined
来源：
BMC Cancer | / 21卷
关键词：
Bone metastases; Bone-targeting agents; Patient-reported pain; Bone-pain related quality of life; Non-interventional; Patterns of care;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 8 条
  • [1] Quality of life and pain in patients with metastatic bone disease from solid tumors treated with bone-targeted agents- a real-world cross-sectional study from Switzerland (SAKK 95/16)
    Ribi, Karin
    Thuerlimann, Beat
    Schaer, Corinne
    Dietrich, Daniel
    Cathomas, Richard
    Zuerrer-Haerdi, Ursina
    von Briel, Thomas
    Anchisi, Sandro
    Bohanes, Pierre
    Blum, Veronika
    von Burg, Philippe
    Mannhart, Meinrad
    Caspar, Clemens B.
    von Moos, Roger
    Mark, Michael
    BMC CANCER, 2021, 21 (01)
  • [2] Patterns of care for patients with metastatic bone disease in solid tumors: A cross-sectional study from Switzerland (SAKK 95/16)
    Mark, Michael
    Thurlimann, Beat
    Ribi, Karin
    Schar, Corinne
    Dietrich, Daniel
    Cathomas, Richard
    Zurrer-Hardi, Ursina
    von Briel, Thomas
    Anchisi, Sandro
    Bohanes, Pierre
    Blum, Veronika
    von Burg, Philipp
    Mannhart, Meinrad
    Caspar, Clemens B.
    von Moos, Roger
    JOURNAL OF BONE ONCOLOGY, 2020, 21
  • [3] A real-world study assessing the use of bone-targeted agents and their impact on bone metastases in patients with prostate cancer treated in clinical practice in Europe
    Body, Jean-Jacques
    von Moos, Roger
    Rider, Alex
    Hallworth, Pamela
    Bhowmik, Debajyoti
    Gatta, Francesca
    Hechmati, Guy
    Qian, Yi
    JOURNAL OF BONE ONCOLOGY, 2019, 14
  • [4] Patterns of care and economic consequences of using bone-targeted agents for castration-sensitive prostate cancer patients with bone metastases to prevent skeletal-related events in Switzerland - the SAKK 95/16 prostate study
    Stoffel, Sandro T.
    von Moos, Roger
    Thurlimann, Beat
    Cathomas, Richard
    Gillessen, Silke
    Zurrer-Hardi, Ursina
    von Briel, Thomas
    Anchisi, Sandro
    Feller, Anita
    Schar, Corinne
    Dietrich, Daniel
    Schwenkglenks, Matthias
    Lupatsch, Judith E.
    Mark, Michael
    SWISS MEDICAL WEEKLY, 2021, 151
  • [5] Denosumab administration for bone metastases from solid tumors: a retrospective cross-sectional study
    Mizuta, Kohei
    Oshiro, Hiromichi
    Katsuki, Ryo
    Tsuha, Yuichi
    Aoki, Yusuke
    Tome, Yasunori
    Nishida, Kotaro
    BMC CANCER, 2023, 23 (01)
  • [6] Denosumab administration for bone metastases from solid tumors: a retrospective cross-sectional study
    Kohei Mizuta
    Hiromichi Oshiro
    Ryo Katsuki
    Yuichi Tsuha
    Yusuke Aoki
    Yasunori Tome
    Kotaro Nishida
    BMC Cancer, 23
  • [7] Symptomatic Skeletal Events and the Use of Bone Health Agents in a Real-World Treated Metastatic Castration Resistant Prostate Cancer Population: Results From the CAPRI-Study in the Netherlands
    Kuppen, Malou C. P.
    Westgeest, Hans M.
    van den Eertwegh, Alfons J. M.
    van Moorselaar, Reindert J. A.
    van Oort, Inge M.
    Tascilar, Metin
    Mehra, Niven
    Lavalaye, Jules
    Somford, Diederik M.
    Aben, Katja K. H.
    Bergman, Andre M.
    de Wit, Ronald
    van den Bergh, A. C. M. Fons
    Uyl-de Groot, Carin A.
    Gerritsen, Winald R.
    CLINICAL GENITOURINARY CANCER, 2022, 20 (01) : 43 - 52
  • [8] Risk factors associated with skeletal-related events following discontinuation of denosumab treatment among patients with bone metastases from solid tumors: A real-world machine learning approach
    Jacobson, Dionna
    Cadieux, Benoit
    Higano, Celestia S.
    Henry, David H.
    Bachmann, Basia A.
    Rehn, Marko
    Stopeck, Alison T.
    Saad, Hossam
    JOURNAL OF BONE ONCOLOGY, 2022, 34
1